Mechanism of 2,3,4',5-Tetrahydroxystilbene 2-O-β-D-Glucoside-Induced Upregulation of Glutamate Transporter 1 Protein Expression in Mouse Primary Astrocytes

GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

(2018) Paramita Mookherjee et al.   JOURNAL OF ALZHEIMERS DISEASE

Tetrahydroxystilbene Glucoside Improves TNF-α-Induced Endothelial Dysfunction: Involvement of TGFβ/Smad Pathway and Inhibition of Vimentin Expression

(2015) Wenjuan Yao et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission

(2015) Ciaran Murphy-Royal et al.   NATURE NEUROSCIENCE

Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes

(2014) Pratap Karki et al.   GLIA

Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats

(2014) Yu-Yan Hu et al.   JOURNAL OF NEUROCHEMISTRY

Harmine mediated neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia

(2014) Piyun Sun et al.   NEUROSCIENCE LETTERS

Potential protection of 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside against staurosporine-induced toxicity on cultured rat hippocampus neurons

(2014) Xiao-Ping Yang et al.   NEUROSCIENCE LETTERS

Upregulation of glutamate transporter GLT-1 by mTOR-Akt-NF-кB cascade in astrocytic oxygen-glucose deprivation

(2013) Yi-Fei Ji et al.   GLIA

TSG (2,3,4’ ,5-tetrahydroxystilbene 2-O-β-D-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia

(2013) Chao Huang et al.   Journal of Neuroinflammation

The Neuropsychological Profile of Alzheimer Disease

(2013) S. Weintraub et al.   Cold Spring Harbor Perspectives in Medicine

Proteomic analysis for anti-atherosclerotic effect of tetrahydroxystilbene glucoside in rats

(2012) WenJuan Yao et al.   BIOMEDICINE & PHARMACOTHERAPY

Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β1–42-injected rats and may be connected to synaptic changes in the hippocampus

(2012) Lin Zhou et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

The effect of 2,3,4′,5-tetrahydroxystilbene-2-0-β-d glucoside on neointima formation in a rat artery balloon injury model and its possible mechanisms

(2012) Xiao-le Xu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation of glutamate transport evokes rapid glutamine release from perisynaptic astrocytes

(2012) Nneka M. Uwechue et al.   JOURNAL OF PHYSIOLOGY-LONDON

2,3,4′,5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle

(2011) Xiao-Le Xu et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation

(2010) Xiaobing Li et al.   NEUROSCIENCE LETTERS

Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation

(2009) Ting Wang et al.   FREE RADICAL BIOLOGY AND MEDICINE

2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-d-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation

(2009) Zequn Jiang et al.   LIFE SCIENCES

Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels

(2009) Claudia Allritz et al.   NEUROCHEMISTRY INTERNATIONAL

GLT-1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine

(2008) Giorgia Fattorini et al.   GLIA